Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudeep Gupta

Showing results (121-130 of 348) with videos related to

Pageof 35
Sort By:
Head & Neck|April 16, 2024
A prospective health economic evaluation to determine the productivity loss due to premature mortality from oral cancer in IndiaArjun Singh, Richard Sullivan, Manasi Bavaskar, et al.
Cancer|May 23, 2012
The use of bevacizumab among women with metastatic breast cancer: a survey on clinical practice and the ongoing controversyShaheenah Dawood, Asim Jamal Shaikh, Thomas A Buchholz, et al.
Cancer Biology & Therapy|September 7, 2017
miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cellsMukul Godbole, Pratik Chandrani, Nilesh Gardi, et al.
Clinical Breast Cancer|December 20, 2017
Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian PopulationTabassum Wadasadawala, Shirley Lewis, Vani Parmar, et al.
South Asian Journal of Cancer|November 16, 2018
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancersAnant Ramaswamy, Vikas Ostwal, Kushal Gupta, et al.
The Lancet. Oncology|September 14, 2015
Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trialRajendra Badwe, Rohini Hawaldar, Nita Nair, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 22, 2017
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinomaBharat Rekhi, Kedar K Deodhar, Santosh Menon, et al.
Pediatric Blood & Cancer|April 11, 2012
Chemotherapy compliance in patients with osteosarcomaJyoti Bajpai, Ajay Puri, Kajal Shah, et al.
Cancer Causes & Control : CCC|November 22, 2015
Understanding rural-urban differences in risk factors for breast cancer in an Indian populationRajini Nagrani, Sharayu Mhatre, Paolo Boffetta, et al.
Ecancermedicalscience|October 5, 2020
Excellent response to erlotinib in breast carcinoma with rare EGFR mutation-a case reportGunjesh Kumar Singh, Jyoti Bajpai, Shalaka Joshi, et al.
Pageof 35

Showing results (121-130 of 348) with videos related to

Sort By:
Pageof 35
Head & Neck|April 16, 2024
A prospective health economic evaluation to determine the productivity loss due to premature mortality from oral cancer in IndiaArjun Singh, Richard Sullivan, Manasi Bavaskar, et al.
Cancer|May 23, 2012
The use of bevacizumab among women with metastatic breast cancer: a survey on clinical practice and the ongoing controversyShaheenah Dawood, Asim Jamal Shaikh, Thomas A Buchholz, et al.
Cancer Biology & Therapy|September 7, 2017
miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cellsMukul Godbole, Pratik Chandrani, Nilesh Gardi, et al.
Clinical Breast Cancer|December 20, 2017
Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian PopulationTabassum Wadasadawala, Shirley Lewis, Vani Parmar, et al.
South Asian Journal of Cancer|November 16, 2018
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancersAnant Ramaswamy, Vikas Ostwal, Kushal Gupta, et al.
The Lancet. Oncology|September 14, 2015
Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trialRajendra Badwe, Rohini Hawaldar, Nita Nair, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 22, 2017
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinomaBharat Rekhi, Kedar K Deodhar, Santosh Menon, et al.
Pediatric Blood & Cancer|April 11, 2012
Chemotherapy compliance in patients with osteosarcomaJyoti Bajpai, Ajay Puri, Kajal Shah, et al.
Cancer Causes & Control : CCC|November 22, 2015
Understanding rural-urban differences in risk factors for breast cancer in an Indian populationRajini Nagrani, Sharayu Mhatre, Paolo Boffetta, et al.
Ecancermedicalscience|October 5, 2020
Excellent response to erlotinib in breast carcinoma with rare EGFR mutation-a case reportGunjesh Kumar Singh, Jyoti Bajpai, Shalaka Joshi, et al.
Pageof 35